This is consistent with the finding that SMA patient cells have low levels of ZPR1 (Gangwani et al., 2001), and accumulate R-loops and DNA damage at higher rates than normal cells (Kannan et al., 2020). Here, ZPR1 is linked to proximal spinal muscular atrophy.